BrainsWay Announces Appointment of Hadar Levy as CEO
BURLINGTON, Mass. and JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment of Hadar Levy, the Company’s Senior Vice President (SVP) and Chief Operating Officer (COO), and a member of BrainsWay’s senior leadership team since 2014, as Chief Executive Officer (CEO). Mr. Levy has been instrumental as a sales, financial and operational leader for the Company throughout his tenure at BrainsWay, previously serving as the Company’s Chief Financial Officer and then General Manager North America, before assuming his role as SVP and COO. Mr. Levy succeeds Christopher R. von Jako, Ph.D., who has decided to step down from the Company to pursue other opportunities.
Related news for (BWAY)
- BrainsWay Enters $20 Million PIPE
- BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
- BrainsWay Announces Appointment of Ido Marom as CFO
- BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
- BrainsWay Announces Appointment of Ami Boehm as New Chairman